A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
about
Vaccines for Pseudomonas aeruginosa: a long and winding roadPrevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDCIdentification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosaMucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa InfectionEvaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines.Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models.A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in miceThe Pseudomonas aeruginosa exopolysaccharide Psl facilitates surface adherence and NF-kappaB activation in A549 cellsProteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strainTh17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumoniaTLR-based immune adjuvants.Antibodies against Marinobacter algicola and Salmonella typhimurium flagellins do not cross-neutralize TLR5 activationFlagellin as carrier and adjuvant in cocaine vaccine development.Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellinRecombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in miceImmunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.Flagellin as an adjuvant: cellular mechanisms and potential.Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.Recent developments for Pseudomonas vaccines.Utilizing bacterial flagellins against infectious diseases and cancers.Bacterial flagellin-a potent immunomodulatory agent.Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.Vaccine strategies against cystic fibrosis pathogens.Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infectionsImmunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia.NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin.Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.
P2860
Q26852817-B6911A34-337A-4938-B07A-FA95A568DD1DQ27323956-3EDDFBEF-9128-44E5-AD8F-603B3B6D405FQ28492950-212D622D-87A6-4EC7-9507-0EDABF0A7C1EQ30430870-2C9C596E-1775-47E4-BDF5-43C91C633FBFQ33553646-639AE38E-FA49-4395-8F2B-6B5BF62A3B8BQ33613907-279B6272-3A00-4D04-ABC3-F5ED71EC6F8FQ33822579-6CB8F30C-E6F8-4798-8FEE-B7D40B96A426Q33905188-5BF33A3B-9911-4A93-AC84-F8D321C74658Q34077478-9DFD82FE-884A-402A-9E40-CE42616D831AQ34134628-91FE6A07-7BD9-4739-AC1F-31F8E7A59F0AQ34313640-A3F749A7-81DA-419E-AF11-5B06DA90E18EQ34400322-76980594-8E67-4BE2-9DE9-F38331D49237Q34478993-98B62041-7876-4D11-803A-4753FA1D65C8Q35057556-75BF6F1E-D134-4229-8ECD-5648C592E8A4Q35209148-E80A6B3D-14E7-411F-AC1D-34DB3C4BAEABQ35749381-E8609911-04B5-49E1-8E57-092E40072FB8Q36391313-BBAB014A-5814-48C9-B7ED-18D21904BCC0Q36676050-966C24E9-5B5B-4225-9256-A63069752A3FQ37095534-2C433AFF-0CB0-423F-858D-D5C690632E9EQ37130379-F2DEFECA-492B-4BE7-A0CF-9A1337882D6EQ37620529-F1C6C4F8-8705-4771-AD32-36155B67C2D9Q37937369-088866AA-D849-4C6B-B095-28DDD39922BAQ38166277-D90A8D9B-41E7-4966-971B-FED2A89490EFQ38634734-DB522094-5B24-490A-B691-F4B6CE78BB0DQ38999243-4B2191A4-1F19-440A-9872-C2A2520E2FE0Q40262035-114FE881-4CE3-4229-9258-7E68D3922336Q42036438-E719D01E-CDD2-47EB-9F8E-62B5E174A2E9Q45174642-B3A4B189-4CD6-4493-9E42-B0789B4114DFQ49702857-3B6BF9C0-2E09-4BB6-BEAF-352FEC6598F2Q53699705-7ECB3063-BAA9-44CE-8BC6-9B71838BBA00
P2860
A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A fusion protein vaccine conta ...... mucoid Pseudomonas aeruginosa.
@en
A fusion protein vaccine conta ...... mucoid Pseudomonas aeruginosa.
@nl
type
label
A fusion protein vaccine conta ...... mucoid Pseudomonas aeruginosa.
@en
A fusion protein vaccine conta ...... mucoid Pseudomonas aeruginosa.
@nl
prefLabel
A fusion protein vaccine conta ...... mucoid Pseudomonas aeruginosa.
@en
A fusion protein vaccine conta ...... mucoid Pseudomonas aeruginosa.
@nl
P2093
P2860
P356
P1476
A fusion protein vaccine conta ...... nmucoid Pseudomonas aeruginosa
@en
P2093
Daniel J Wozniak
Haiping Lu
Nancy D Kock
Steven B Mizel
P2860
P304
P356
10.1128/IAI.00054-09
P407
P577
2009-04-06T00:00:00Z